MOTCO’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50
Closed 775
2019
Q4
$0 Hold
50
﹤0.01% 566
2019
Q3
$0 Hold
50
﹤0.01% 807
2019
Q2
$0 Hold
50
﹤0.01% 858
2019
Q1
$0 Hold
50
﹤0.01% 589
2018
Q4
$0 Hold
50
﹤0.01% 617
2018
Q3
$0 Hold
50
﹤0.01% 582
2018
Q2
$0 Hold
50
﹤0.01% 557
2018
Q1
$0 Hold
50
﹤0.01% 595
2017
Q4
$0 Hold
50
﹤0.01% 609
2017
Q3
$0 Hold
50
﹤0.01% 620
2017
Q2
$0 Hold
50
﹤0.01% 674
2017
Q1
$0 Hold
50
﹤0.01% 662
2016
Q4
$0 Hold
50
﹤0.01% 695
2016
Q3
$0 Buy
+50
New +$13 ﹤0.01% 687

MOTCO's GCVRZ Position: Q1 2020 in Review

MOTCO sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 50 shares.

MOTCO first reported a position in GCVRZ in Q3 2016 and held it in 14 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • MOTCO reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • MOTCO sold 50 Sanofi Contingent Value Rights shares in Q1 2020.
  • MOTCO first reported a position in Sanofi Contingent Value Rights in Q3 2016 and held it in 14 quarters.
  • MOTCO's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on MOTCO's 13F filing for Q1 2020, filed 6 May 2020.